Lipvas 10 Tablet contains Atorvastatin 10mg, a lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the management of hypercholesterolemia and mixed dyslipidemia, aiming to reduce elevated levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while modestly increasing high-density lipoprotein cholesterol (HDL-C). Atorvastatin exerts its therapeutic effect by selectively inhibiting HMG-CoA reductase, a key enzyme involved in the biosynthesis of cholesterol in the liver. This inhibition leads to an upregulation of LDL receptors on hepatocyte membranes, enhancing the clearance of LDL cholesterol from the bloodstream. Lipvas 10 is prescribed as part of a comprehensive treatment plan including diet, exercise, and lifestyle modifications to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with atherosclerotic cardiovascular disease or those at high risk. It is also used for primary prevention in individuals with multiple risk factors. The tablet is administered orally, typically once daily, with or without food. Common adverse effects may include headache, myalgia, and gastrointestinal disturbances. Regular monitoring of liver function and lipid profiles is recommended during therapy to ensure safety and efficacy.